Document Detail


Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.
MedLine Citation:
PMID:  21378081     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Studies suggest that in smokers attempting to quit smoking, the occurrence of stressful events is associated with smoking relapse. The purpose of this study was to determine the effect of bupropion (an agent known to increase smoking cessation rates) on the craving, withdrawal, and mood response to stressful tasks administered in a laboratory setting.
METHODS: Response to three tasks (a speech, math, and cold pressor task) was measured in 65 smokers during ad libitum smoking. Smokers were then randomized to either bupropion or placebo. Fourteen days after starting medication, 43 subjects (28 receiving bupropion and 15 receiving placebo) quit smoking and laboratory procedures were repeated on the third day of abstinence.
RESULTS: Prior to cessation, stressors presented in a laboratory setting increased craving, nicotine withdrawal symptoms, and subjective distress but decreased positive affect. Thirty minutes of relaxation after the stressors did not result in these measures returning to prestress levels. During the nicotine withdrawal period, stress-induced responses were generally smaller than during the precessation period. Bupropion (relative to placebo) reduced overall levels of craving and withdrawal symptoms but did not have significant effects on response to stress during the nicotine withdrawal period.
CONCLUSIONS: This study demonstrates that stress results in sustained increases in craving and withdrawal symptoms and changes in mood symptoms and that bupropion affects overall levels of these symptoms. Further research is needed to determine if modifying response to stress is predictive of an effective treatment for facilitating smoking cessation.
Authors:
Michael Kotlyar; David Drone; Paul Thuras; Dorothy K Hatsukami; Lisa Brauer; David E Adson; Mustafa al'Absi
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-03-04
Journal Detail:
Title:  Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco     Volume:  13     ISSN:  1469-994X     ISO Abbreviation:  Nicotine Tob. Res.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-30     Completed Date:  2012-07-31     Revised Date:  2014-04-08    
Medline Journal Info:
Nlm Unique ID:  9815751     Medline TA:  Nicotine Tob Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  492-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Affect / drug effects*
Aged
Antidepressive Agents, Second-Generation / administration & dosage,  pharmacology*,  therapeutic use
Bupropion / administration & dosage,  pharmacology*,  therapeutic use
Counseling
Female
Humans
Male
Middle Aged
Smoking Cessation / methods*
Stress, Psychological / complications*,  psychology
Substance Withdrawal Syndrome / drug therapy*,  prevention & control,  psychology
Tobacco Use Disorder / drug therapy,  prevention & control
Treatment Outcome
Young Adult
Grant Support
ID/Acronym/Agency:
K23DA017307/DA/NIDA NIH HHS; M01-RR00400/RR/NCRR NIH HHS; R01 DA016351/DA/NIDA NIH HHS; R03DA013435/DA/NIDA NIH HHS; R21CA088272/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Second-Generation; 01ZG3TPX31/Bupropion
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on n...
Next Document:  Whole body hypothermia has central and peripheral influences on elbow flexor performance.